NRx Pharmaceuticals, Inc.
Company

NRx Pharmaceuticals, Inc.

Biotechnology Research 1201 N Market Street 14 employees NRXP
Employees
14
Contacts
4
Emails
4
Phones
3

NRx Pharmaceuticals, Inc. Overview

Headquarters
1201 N Market Street
Industry
Biotechnology Research
Employees
14
Founded
2015
Stock Symbol
NRXP
Funding
3.5M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About NRx Pharmaceuticals, Inc.

We are NRx – a pioneering and focused CNS biopharma company, dedicated to meeting unmet medical needs for those with suicidal depression, suicidal bipolar depression, and post-traumatic stress disorder (PTSD). The company has filed an Abbreviated New Drug Application (ANDA) for NRX-100, preservative-free IV ketamine and has initiated filing of an NDA for NRX-100 in people with suicidal depression.

NRx Pharmaceuticals, Inc. Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
3
75.0% coverage

NRx Pharmaceuticals, Inc. Org Chart

Sample employees and titles
Name Title Contact
Dr. Dennis K. Mcbride
Email Phone
Jonathan C. Javitt, M.d., M.p.h. Founder, Chairman, and CEO, Nrx
Email Phone
Stephen Cunnion Senior Fellow, Medical Director
Email Phone
Drew Evans Director of Digital Communications
Email

Employees by Management Level

Director 2 profiles
Executive 1 profile

Compare Similar Companies to NRx Pharmaceuticals, Inc.